Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Liver disorder? 208 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 208 reports of Liver disorder have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.3% of all adverse event reports for ESOMEPRAZOLE.

208
Reports of Liver disorder with ESOMEPRAZOLE
0.3%
of all ESOMEPRAZOLE reports
30
Deaths
117
Hospitalizations

How Dangerous Is Liver disorder From ESOMEPRAZOLE?

Of the 208 reports, 30 (14.4%) resulted in death, 117 (56.3%) required hospitalization, and 21 (10.1%) were considered life-threatening.

Is Liver disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 208 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Liver disorder?

METHOTREXATE (3,119) ADALIMUMAB (2,502) ETANERCEPT (1,990) TOCILIZUMAB (1,853) ABATACEPT (1,759) RITUXIMAB (1,736) ACETAMINOPHEN (1,723) LEFLUNOMIDE (1,599) TOFACITINIB (1,584) HYDROXYCHLOROQUINE (1,514)

Which ESOMEPRAZOLE Alternatives Have Lower Liver disorder Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Liver disorder Reports All Drugs Causing Liver disorder ESOMEPRAZOLE Demographics